Organism name | Enantia chlorantha |
---|---|
Genus | Enantia |
Family | Annonaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Enantia |
---|---|
Linked NCBI taxonomy ID | 320276 |
Linked level | genus |
Family in NCBI taxonomy | Pieridae |
---|---|
ID | 7114 |
Kingdom (Superkingdom) in NCBI taxonomy | Metazoa |
---|---|
ID | 33208 |
Plant class | |
---|---|
ID |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00029094
![]() |
Xylopinine
/ Tetrahydropseudopalmatine |
CHEMBL465824
CHEMBL2357282 |
1 / 0 / 0 | No. 37 | No. 4 |
![]() |
||
C00026149
![]() |
Corypalmine
/ Tetrahydrojatrorrhizine |
CHEMBL2334885
CHEMBL2334886 |
4 / 3 / 0 | No. 37 | No. 4 |
![]() |
||
C00026150
![]() |
Tetrahydropalmatine
/ dl-Tetrahydropalmatine / (+/-)-Tetrahydropalmatine |
CHEMBL187892
CHEMBL487182 CHEMBL2334889 |
8 / 5 / 2 | No. 37 | No. 4 |
![]() |
||
C00025632
![]() |
Isocorypalmine
/ (-)-Isocorypalmine / Tetrahydrocolumbamine / O10-Methylstepholidine |
CHEMBL2334891
CHEMBL2334892 |
4 / 3 / 0 | No. 37 | No. 4 |
![]() |
||
C00025890
![]() |
Liridine
/ Homomoschatoline / O-Methylmoschatoline / O-Methylisomoschatoline |
CHEMBL227533
|
No. 74 |
![]() |
||||
C00001878
![]() |
Liriodenine
/ Oxoushinsunine / Spermatheridine |
CHEMBL37736
|
C026980
|
5 / 3 / 1 | No. 74 |
![]() |
||
C00025935
![]() |
Lysicamine
/ Oxonuciferine |
CHEMBL510090
|
C069090
|
No. 74 |
![]() |
|||
C00026143
![]() |
Govanine
/ Pseudocolumbamine |
CHEMBL1197451
|
No. 155 | No. 4 |
![]() |
|||
C00025342
![]() |
Pseudopalmatine
/ 5,6-Dihydro-8-demethylcoralyne |
CHEMBL376300
|
No. 155 | No. 4 |
![]() |
|||
C00027159
![]() |
Depiline
/ Palmatine / Berbericinine / O,O-Dimethyldemethyleneberberine |
CHEMBL206106
|
C005413
|
8 / 13 / 13 | 8 / 0 | No. 155 | No. 4 |
![]() |
C00001874
![]() |
Neprotin
/ Neprotine / Yatrorizine / Jatrorrhizine |
CHEMBL251055
|
C055785
|
14 / 27 / 20 | 1 / 0 | No. 155 | No. 4 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00001874 C00026150 C00027159 | 0 / 1 |
P08908 | 5-hydroxytryptamine receptor 1A | Serotonin receptor | C00025632 C00026149 C00026150 | 1 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00025632 C00026149 C00026150 | 0 / 0 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00025632 C00026149 C00026150 | 2 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00025632 C00026149 C00026150 | 0 / 0 |
P43351 | DNA repair protein RAD52 homolog | Unclassified protein | C00001874 C00029094 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00001874 C00027159 | 11 / 10 |
P39748 | Flap endonuclease 1 | Enzyme | C00001874 | 0 / 0 |
P30926 | Neuronal acetylcholine receptor subunit beta-4 | CHRN beta | C00001878 | 0 / 0 |
P32297 | Neuronal acetylcholine receptor subunit alpha-3 | CHRN alpha | C00001878 | 1 / 0 |
P17787 | Neuronal acetylcholine receptor subunit beta-2 | CHRN beta | C00001878 | 1 / 1 |
P43681 | Neuronal acetylcholine receptor subunit alpha-4 | CHRN alpha | C00001878 | 1 / 1 |
Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | C00001874 | 1 / 0 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00001874 | 1 / 1 |
Q14761 | Protein tyrosine phosphatase receptor type C-associated protein | Enzyme | C00001878 | 0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00027159 | 0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00027159 | 0 / 1 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00026150 | 1 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00027159 | 0 / 0 |
P13726 | Tissue factor | Membrane receptor | C00026150 | 0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00027159 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00026150 | 1 / 1 |
P04062 | Glucosylceramidase | Enzyme | C00001874 | 6 / 4 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00027159 | 1 / 1 |
P06746 | DNA polymerase beta | Enzyme | C00001874 | 0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00001874 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00001874 | 4 / 3 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00001874 | 4 / 1 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00001874 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00001874 | 0 / 0 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00001874 | 0 / 0 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00027159 | 1 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
332 | BIRC5, API4, EPR-1 | baculoviral IAP repeat containing 5 |
C00001874
C00027159
|
6352 | CCL5, D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228, eoCP | chemokine (C-C motif) ligand 5 |
C00027159
|
6348 | CCL3, G0S19-1, LD78ALPHA, MIP-1-alpha, MIP1A, SCYA3 | chemokine (C-C motif) ligand 3 |
C00027159
|
6351 | CCL4, ACT2, AT744.1, G-26, HC21, LAG-1, LAG1, MIP-1-beta, MIP1B, MIP1B1, SCYA2, SCYA4 | chemokine (C-C motif) ligand 4 |
C00027159
|
6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00027159
|
3570 | IL6R, CD126, IL-6R-1, IL-6RA, IL6Q, IL6RA, IL6RQ, gp80 | interleukin 6 receptor |
C00027159
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00027159
|
7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A |
C00027159
|
OMIM | preferred title | UniProt |
---|---|---|
#103780 | Alcohol dependence |
P14416
|
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#600513 | Epilepsy, nocturnal frontal lobe, 1; enfl1 |
P43681
|
#605375 | Epilepsy, nocturnal frontal lobe, 3; enfl3 |
P17787
|
#615363 | Estrogen resistance; estrr |
P03372
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#232300 | Glycogen storage disease ii |
P10253
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#159900 | Myoclonic dystonia |
P14416
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#168600 | Parkinson disease, late-onset; pd |
P04062
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#614674 | Periodic fever, menstrual cycle-dependent |
P08908
|
#172700 | Pick disease of brain |
P10636
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#612052 | Smoking as a quantitative trait locus 3; sqtl3 |
P32297
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
KEGG | name | UniProt |
---|---|---|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
|
H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00807 | Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) |
P17787
(related)
P43681 (related) |
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|